# Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients

> **NCT03867071** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 60 (actual)

## Conditions studied

- Trauma

## Interventions

- **OTHER:** recombinant erythropoietin injection
- **OTHER:** placebo injection

## Key facts

- **NCT ID:** NCT03867071
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03867071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03867071, "Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03867071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*